ArticleMolecular biotechnology2026

BAX as a Biomarker for Predicting Immunotherapeutic Efficacy in Uveal Melanoma Patients: A Comprehensive Analysis.

Yao Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.